As co-author of the COAPT study, Dr. Vivek Rajagopal of Piedmont Heart describes the moment when he realized its huge impact on the field. The COAPT trial evaluated MitraClip percutaneous therapy for heart failure patients with functional mitral regurgitation. Presented at Napa Valley Cardiology Conference 2019.
Learn more at
www.piedmont.org/heartlearning
www.piedmont.org/napa
7 окт 2019
